The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Brad Reisfeld, Colorado State University (THE CONVERSATION) A vast number of chemicals ...
(Nanowerk News) Animal testing has long been a fixture of medical and pharmaceutical research, but alternative methods are growing more and more important. Innovative methods allow for research aimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results